Edward van der Horst
Hoofd Techniek/Wetenschap/O&O bij SENSEI BIOTHERAPEUTICS, INC.
Vermogen: 56 070 $ op 30-04-2024
Actieve functies van Edward van der Horst
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 07-12-2022 | - |
| Corporate Officer/Principal | 01-09-2019 | 07-12-2022 |
Loopbaan van Edward van der Horst
Eerdere bekende functies van Edward van der Horst
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Zenith Epigenetics Ltd.
 Zenith Epigenetics Ltd. Miscellaneous Commercial ServicesCommercial Services Zenith Epigenetics Ltd. operates as a Canadian clinical-stage biotechnology company. The private company is based in Calgary, Canada. | Corporate Officer/Principal | 01-07-2017 | 01-08-2019 |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Corporate Officer/Principal | 01-10-2010 | 01-01-2017 |
Opleiding van Edward van der Horst
| Max Planck Institute of Biochemistry | Doctorate Degree |
| Ludwig-Maximilians-Universität München | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Duitsland | 3 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Zenith Epigenetics Ltd.
Zenith Epigenetics Ltd. Miscellaneous Commercial ServicesCommercial Services Zenith Epigenetics Ltd. operates as a Canadian clinical-stage biotechnology company. The private company is based in Calgary, Canada. | Commercial Services |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |